White matter integrity correlates with cognition and disease severity in Fabry disease

Leonardo Ulivi1,2, Baris Kanber3,4, Ferran Prados3,4,5

  • 1Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, London WC1B 5EH, UK.

Insights

Diffusion tensor imaging (DTI) reveals widespread white matter damage in Fabry disease, even in normal-appearing areas. These diffusion measures correlate with cognitive function, disease severity, and a key biomarker, showing potential for monitoring Fabry disease progression.

Area of Science:

  • Neuroimaging
  • Neurology
  • Biomarker Discovery

Background:

  • Cerebral white matter pathology is a frequent manifestation of Fabry disease, observable as white matter hyperintensities on MRI.
  • Diffusion tensor imaging (DTI) is a sensitive MRI technique for quantifying white matter microstructural damage and holds potential as a disease biomarker.

Purpose of the Study:

  • To evaluate the pattern of DTI abnormalities in Fabry disease.
  • To correlate these DTI findings with cognitive impairment, mood, anxiety, disease severity, and plasma lyso-Gb3 levels.

Main Methods:

  • DTI MRI was performed on 31 patients with Fabry disease and 19 healthy controls.
  • Neuropsychological testing assessed processing speed, executive function, anxiety, and depression.
  • Voxelwise analysis using tract-based spatial statistics was employed to analyze diffusion abnormalities.

Main Results:

  • Patients with Fabry disease exhibited lower fractional anisotropy and higher mean diffusivity in white matter compared to controls.
  • Diffusion abnormalities were widespread and present even in normal-appearing white matter.
  • DTI measures correlated significantly with cognitive function (processing speed), disease severity (Mainz Severity Score Index), and plasma lyso-Gb3 levels.

Conclusions:

  • DTI confirms extensive microstructural white matter disruption in Fabry disease, extending beyond visible lesions.
  • Diffusion measures are promising quantitative biomarkers for monitoring Fabry disease severity and progression due to their strong correlations with clinical outcomes and biomarkers.